RIGEL PHARMACEUTICALS INC
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Nov 2, 2026 (7 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 17, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Aug 14, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 2, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 27, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 22, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 13, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 7, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Nov 5, 2025 | Jefferies | upgrade | Hold → Buy | $42 | 52% |
| Nov 5, 2025 | Cantor Fitzgerald | maintain | Neutral → Neutral | $38 | 50% |
| Oct 8, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $57 | 44% |
| Aug 6, 2025 | Cantor Fitzgerald | maintain | Neutral → Neutral | $32 | 50% |
| May 7, 2025 | Cantor Fitzgerald | maintain | Neutral → Neutral | $23 | 50% |
| Mar 6, 2025 | Citigroup | maintain | Buy → Buy | $55 | 54% |
| Mar 5, 2025 | B. Riley Securities | maintain | Neutral → Neutral | $24 | 54% |
| Mar 5, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $57 | 44% |
| Jan 23, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $57 | 44% |
| Jan 22, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $57 | 44% |
| Jan 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $57 | 44% |
| Dec 10, 2024 | Cantor Fitzgerald | maintain | Neutral → Neutral | $25 | 50% |
| Dec 10, 2024 | B. Riley Securities | maintain | Neutral → Neutral | $20 | 54% |
| Dec 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $57 | 44% |
| Dec 6, 2024 | B. Riley Securities | maintain | Neutral → Neutral | $27 | 54% |
| Nov 14, 2024 | Piper Sandler | maintain | Neutral → Neutral | $23 | 54% |
| Nov 12, 2024 | Citigroup | maintain | Buy → Buy | $49 | 54% |
| Oct 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $57 | 44% |
| Aug 9, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $57 | 44% |
| Jun 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jun 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jun 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| May 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Mar 7, 2024 | Citigroup | maintain | Buy → Buy | $4 | 54% |
| Mar 6, 2024 | Cantor Fitzgerald | maintain | Neutral → Neutral | $3 | 50% |
| Mar 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Mar 6, 2024 | B. Riley Securities | maintain | Neutral → Neutral | $1.25 | 54% |
| Feb 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jan 4, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Dec 8, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Aug 2, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| May 3, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $15 | 44% |
| Mar 9, 2023 | Citigroup | maintain | — → Buy | $3 | 54% |
| Mar 8, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $15 | 44% |
| Dec 2, 2022 | Citigroup | upgrade | Neutral → Buy | $0 | 54% |
| Nov 4, 2022 | BMO Capital | maintain | — → Outperform | $3 | 53% |
| Aug 18, 2022 | HC Wainwright & Co. | maintain | — → Buy | $15 | 44% |
| Aug 17, 2022 | Piper Sandler | maintain | — → Neutral | $2 | 54% |
| Jun 9, 2022 | BMO Capital | maintain | — → Outperform | $3 | 53% |
| Jun 9, 2022 | B. Riley Securities | maintain | — → Neutral | $1.25 | 54% |
| Jun 9, 2022 | Citigroup | downgrade | Buy → Neutral | $0.8 | 54% |
| Jun 8, 2022 | HC Wainwright & Co. | maintain | — → Buy | $7 | 44% |
No cross-platform signals in the last 90 days